Angiotensin peptides in treating marfan syndrome and related disorders
US9107870B2 · kind B2 · utility
0Cited by
5References
14Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 3, 2014 |
| Grant date | Aug 18, 2015 |
| Priority date | — |
| Expiry date | Oct 3, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides, among other things, methods of treating Marfan Syndrome and/or a Marfan-related disorder including administering to a subject suffering from or susceptible to Marfan Syndrome and/or a Marfan-related disorder an angiotensin (1-7) peptide. In some embodiments, the angiotensin (1-7) peptide is administered at an effective dose periodically at an administration interval such that at least one symptom or feature of Marfan Syndrome and/or a Marfan-related disorder is reduced in intensity, severity, duration, or frequency or has delayed in onset.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.